The specific upregulation of LEP in OBS and CREM2 in NW cultures further highlights the complex and context-dependent nature of folic acid’s influence on gene expression, indicating potential therapeutic pathways for tailored folic acid interventions in SLE, particularly in individuals with obesity. The gene discussed is LEP; the disease is obesity disorder.